Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor

For patients with anaplastic Wilms tumor (WiT), metastasis and recurrence are common, and prognosis is generally poor. Novel therapies are needed to improve outcomes for patients with this high-risk WiT. A potential contributor to WiT development is constitutive activation of AKT by insulin-like gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Nelson, Marie V., Bailey, Christopher, Zhang, Peng, Zheng, Pan, Dome, Jeffrey S., Liu, Yang, Wang, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319145/
https://www.ncbi.nlm.nih.gov/pubmed/34155347
http://dx.doi.org/10.1038/s41388-021-01907-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319145/
https://www.ncbi.nlm.nih.gov/pubmed/34155347
http://dx.doi.org/10.1038/s41388-021-01907-1

Ejemplares similares